ENDRA Life Sciences Inc(NDRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NDRA ENDRA Life Sciences Inc

Market Closed 06-05 16:00:00 EDT

4.23

-0.54

-11.32%

盘后4.23

+0.000.00%

17:17 EDT

High4.52	Low4.21	Vol7.41K
Open4.21	D1 Closing4.77	Amplitude6.50%
Mkt Cap7.82M	Tradable Cap2.70M	Total Shares1.85M
T/O32.87K	T/O Rate1.16%	Tradable Shares638.85K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NDRA","market":"US","secType":"STK","nameCN":"ENDRA Life Sciences Inc","latestPrice":4.23,"timestamp":1780689600000,"preClose":4.77,"halted":0,"volume":7409,"hourTrading":{"tag":"盘后","latestPrice":4.23,"preClose":4.23,"latestTime":"17:17 EDT","volume":11,"amount":46.13,"timestamp":1780694235325,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.11320754716981116,"floatShares":638845,"shares":1848500,"eps":-7.706966,"marketStatus":"Market Closed","change":-0.54,"latestTime":"06-05 16:00:00 EDT","open":4.21,"high":4.52,"low":4.21,"amount":32871,"amplitude":0.06499,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-7.706966,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.77,"preHourTrading":{"tag":"盘前","latestPrice":4.5,"preClose":4.77,"latestTime":"05:22 EDT","volume":1,"amount":4.5,"timestamp":1780651332791,"change":-0.27,"changeRate":-0.056604,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.23,"preClose":4.23,"latestTime":"17:17 EDT","volume":11,"amount":46.13,"timestamp":1780694235325,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5200179569340782},"requestUrl":"/m/hq/s/NDRA/wiki","defaultTab":"wiki","newsList":[{"id":"2640590414","title":"ENDRA Life Sciences (NDRA) Gets a Buy from Ascendiant","url":"https://stock-news.laohu8.com/highlight/detail?id=2640590414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640590414?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:37","pubTimestamp":1780490228,"startTime":"0","endTime":"0","summary":"Ascendiant analyst Edward Woo maintained a Buy rating on ENDRA Life Sciences on May 31 and set a price target of $25.00. Woo covers the Healthcare ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/endra-life-sciences-ndra-gets-a-buy-from-ascendiant-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/endra-life-sciences-ndra-gets-a-buy-from-ascendiant-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","XLV","NDRA","BK4585","XBI","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640953590","title":"ENDRA Life Sciences Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2640953590","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640953590?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:27","pubTimestamp":1780309620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NDRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 01, 2026 06:27 ET (10:27 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638649156","title":"ENDRA Life Sciences prices $3.8 million private placement at $6.57 per share with warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2638649156","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638649156?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:08","pubTimestamp":1779962887,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences entered a private placement to sell 578,387 shares of common stock and/or prefunded warrants to an accredited investor.The deal includes common warrants to buy up to 1,156,774 shares at USD 6.57 per share; securities priced at USD 6.57 per share.Use of proceeds earmarked for working capital and general corporate purposes, subject to restrictions in a side letter.Some warrant exercisability requires stockholder approval; Lucid Capital Markets served as sole placement agent.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL95LBhM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636073341","title":"ENDRA Life Sciences Q1 EPS $(1.09) Beats $(1.14) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2636073341","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636073341?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:04","pubTimestamp":1779105877,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.14) by 4.39 percent. This is a 41.4 percent increase over losses of $(1.86) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52630633/endra-life-sciences-q1-eps-1-09-beats-1-14-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636078418","title":"ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2636078418","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636078418?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:00","pubTimestamp":1779105601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nTUA5DQNJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635584600","title":"ENDRA Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635584600","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635584600?lang=en_us&edition=fundamental","pubTime":"2026-05-16 05:04","pubTimestamp":1778879086,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences Inc reports results for the quarter ended March 31 - Earnings SummaryENDRA Life Sciences Inc NDRA.OQ reported a quarterly adjusted loss of $1.80 per share for the quarter ended Mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL8N41S25V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635037612","title":"ENDRA net loss widens 26.55% to $1.31 million in Q1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037612","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635037612?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:05","pubTimestamp":1778875500,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences posted a net loss of USD 1.31 million for the quarter ended March 31, 2026, widening from USD 1.04 million a year earlier.Research and development expense rose 47% to USD 776,410, while general and administrative costs climbed 60% to USD 1.39 million.Sales and marketing expense fell 94% to USD 4,278; revenue remained at no revenue.Other expense increased to USD 862,315, driven by a USD 859,761 change in fair value of digital assets.Cash totaled USD 356,462 at March 31, 2026; board initiated a review of strategic alternatives, while cost cuts are expected to delay timing of a future De Novo FDA submission for the TAEUS liver application.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. publishe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL5Vq9Pp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635744167","title":"Endra Life Sciences reports multi-site validation of TAEUS Liver device","url":"https://stock-news.laohu8.com/highlight/detail?id=2635744167","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635744167?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:56","pubTimestamp":1778777815,"startTime":"0","endTime":"0","summary":"Endra Life Sciences (NDRA) announced multi-site clinical validation results for TAEUS Liver that demonstrate “strong” concordance with MRI-PDFF, hi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/endra-life-sciences-reports-multi-site-validation-of-taeus-liver-device-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/endra-life-sciences-reports-multi-site-validation-of-taeus-liver-device-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635758594","title":"ENDRA Life Sciences Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2635758594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635758594?lang=en_us&edition=fundamental","pubTime":"2026-05-14 03:48","pubTimestamp":1778701698,"startTime":"0","endTime":"0","summary":"15:43 EDT ENDRA Life Sciences (NDRA) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/endra-life-sciences-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/endra-life-sciences-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NDRA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635730480","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 03:38 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2635730480","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635730480?lang=en_us&edition=fundamental","pubTime":"2026-05-14 03:38","pubTimestamp":1778701101,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 03:38 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nAQN2LYWVG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634283759","title":"ENDRA Life Sciences Inc  expected to post a loss of $1.23 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634283759","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634283759?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:20","pubTimestamp":1778498415,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences Inc  expected to post a loss of $1.23 a share - Earnings Preview ENDRA Life Sciences Inc NDRA.OQ NDRA.O is expected to  show no change in quarterly revenue when it reports  results","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O0YF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629036172","title":"ENDRA risks Nasdaq delisting after falling below $2.5 million equity requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2629036172","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629036172?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:01","pubTimestamp":1776772909,"startTime":"0","endTime":"0","summary":"Nasdaq warned ENDRA Life Sciences on April 20, 2026 that it is out of compliance with Listing Rule 5550 after reporting stockholders’ equity of 2,260,120 in its 2025 Form 10-K.Staff letter said ENDRA faces delisting unless it requests a hearing before Nasdaq Hearings Panel.ENDRA plans to request hearing, which would stay delisting action pending panel decision.Company is evaluating steps to regain minimum 2,500,000 stockholders’ equity requirement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL2z3BL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624551895","title":"ENDRA Life Sciences Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2624551895","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624551895?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:55","pubTimestamp":1774997718,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences Inc reports results for the quarter ended September 30 - Earnings SummaryENDRA Life Sciences Inc NDRA.OQ reported a quarterly adjusted loss of $2.10 per share for the quarter ended","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL8N40J2KY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624553765","title":"ENDRA Life Sciences Q4 EPS $(3.25) Misses $(1.95) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2624553765","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624553765?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:22","pubTimestamp":1774992172,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(3.25) per share which missed the analyst consensus estimate of $(1.95) by 66.67 percent. This is a 55.78 percent increase over losses of $(7.35) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51586945/endra-life-sciences-q4-eps-3-25-misses-1-95-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ENDRA Life Sciences Q4 EPS $(3.25) Misses $(1.95) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624663530","title":"ENDRA Life Sciences Q4 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2624663530","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624663530?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:29","pubTimestamp":1774988984,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences Q4 net loss narrowsOverviewUS thermoacoustic imaging firm's Q4 operating expenses fell, narrowing net loss yr/yrCompany initiated review of strategic alternatives to maximize share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL1N40J179:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624537904","title":"ENDRA FY25 net loss narrows to $7 million; operating expenses fall to $5.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624537904","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624537904?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:08","pubTimestamp":1774987682,"startTime":"0","endTime":"0","summary":"ENDRA reported a net loss of $7.0 million for fiscal 2025, narrowing from $11.5 million.Operating expenses fell to $5.8 million from $10.8 million, due to streamlining actions taken throughout 2024.Cash and cash equivalents ended 2025 at $762,365; digital assets totaled $2.0 million.Board initiated a process on March 25, 2026 to evaluate strategic alternatives to maximize shareholder value.CEO Alexander Tokman said ENDRA strengthened clinical evidence for TAEUS Liver and remains confident in the technology’s long-term potential while continuing to execute during the review process.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. published the original content used to generate this news brief via Business Wire  o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbXd3Zs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624537674","title":"Press Release: ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2624537674","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624537674?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:05","pubTimestamp":1774987500,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences Inc.  , a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease , today reported financial results for the quarter and year ended December 31, 2025, and provided a business update.--  On March 25, 2026, the Company announced that its Board of. Directors has initiated a process to evaluate strategic. --  The Company intends to continue executing on its strategic and. operating initiatives during the review process, and has not set a. --  On November 20, 2025, ENDRA announced positive results from its. feasibility study that demonstrated the ability of TAEUS Liver, as. redesigned in 2025, to accurately quantify liver fat fraction -- a. key MASLD/MASH biomarker -- with a Pearson correlation coefficient. concordance with MRI-PDFF, the industry's gold standard for. thresholds of 12-17% and 20-22%, thereby positioning the device as. a clinical SLD tool for future use in pharmaceutical trials.for long-term monitoring of S","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4022","NDRA","BK4082","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622875801","title":"ENDRA Life Sciences Inc  expected to post a loss of $1.23 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2622875801","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622875801?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:17","pubTimestamp":1774624666,"startTime":"0","endTime":"0","summary":"ENDRA Life Sciences Inc  expected to post a loss of $1.23 a share - Earnings Preview ENDRA Life Sciences Inc NDRA.OQ NDRA.O is expected to  show no change in quarterly revenue when it reports  results","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F1GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622079776","title":"ENDRA Life Sciences Inc - on March 19 ,Reduced Number of Employees in Order to Reduce Cash Expenditures and Extend Its Operational Runway- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2622079776","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622079776?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:25","pubTimestamp":1774445115,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D0GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NDRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622079459","title":"BRIEF-Endra Life Sciences Initiates Review Of Strategic Alternatives To Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2622079459","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622079459?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:18","pubTimestamp":1774444711,"startTime":"0","endTime":"0","summary":"BRIEF-Endra Life Sciences Initiates Review Of Strategic Alternatives To Maximize Shareholder ValueENDRA Life Sciences Inc NDRA.O:ENDRA LIFE SCIENCES INITIATES REVIEW OF STRATEGIC ALTERNATIVES TO MAXIM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nTUANWPMW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDRA","BK4082"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.endrainc.com","stockEarnings":[{"period":"1week","weight":-0.2309},{"period":"1month","weight":-0.1296},{"period":"3month","weight":0.2589},{"period":"6month","weight":-0.2903},{"period":"1year","weight":0.2515},{"period":"ytd","weight":-0.0662}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.052625},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.058832},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.150883},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.084253},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.107146},{"month":6,"riseRate":0.666667,"avgChangeRate":0.00325},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.005394},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.12196},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.06489},{"month":10,"riseRate":0.222222,"avgChangeRate":0.02267},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.075145},{"month":12,"riseRate":0.555556,"avgChangeRate":0.176663}],"exchange":"NASDAQ","name":"ENDRA Life Sciences Inc","nameEN":"ENDRA Life Sciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ENDRA Life Sciences Inc(NDRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ENDRA Life Sciences Inc(NDRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ENDRA Life Sciences Inc,NDRA,ENDRA Life Sciences Inc股票,ENDRA Life Sciences Inc股票老虎,ENDRA Life Sciences Inc股票老虎国际,ENDRA Life Sciences Inc行情,ENDRA Life Sciences Inc股票行情,ENDRA Life Sciences Inc股价,ENDRA Life Sciences Inc股市,ENDRA Life Sciences Inc股票价格,ENDRA Life Sciences Inc股票交易,ENDRA Life Sciences Inc股票购买,ENDRA Life Sciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ENDRA Life Sciences Inc(NDRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ENDRA Life Sciences Inc(NDRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction